118 Delayed Cranial Decompression Rates After Initiation of Unfractionated Heparin Versus Low-Molecular-Weight Heparin in Traumatic Brain Injury

Abstract

INTRODUCTION: Both unfractionated heparin (UH) and low-molecular weight heparin (LMWH) are routinely used prophylactically after traumatic brain injury (TBI) to prevent deep vein thrombosis. Their comparative risk for intracranial hemorrhage (ICH) development or worsening necessitating cranial decompression after prophylaxis initiation is unclear. Furthermore, the absence of a specific antidote for LMWH may lead to UH being used more often for high-risk patients. METHODS: We compared the incidence of delayed cranial decompression occurring after initiation of prophylactic UH vs. LMWH using the National Trauma Data Bank. Cranial decompression procedures included craniotomy, craniectomy, and external ventricular drain placement. Multiple imputation was utilized for missing data. To account for selection bias between UH and LMWH, we conducted propensity score matching using factors that were significantly different between the two groups. The matched UH and LMWH groups were then compared using logistic regression for the primary outcome of post-prophylaxis cranial decompression. RESULTS: A total of 218,594 TBI patients were included, with 61,998 (28.3%) receiving UH and 156,596 (71.7%) receiving LMWH as DVT prophylaxis. The UH group had significantly higher patient age, BMI, comorbidity rates, injury severity score, and worse motor Glasgow coma scale. After matching the UH and LMWH groups for these factors, logistic regression demonstrated lower rates of post-prophylaxis cranial decompression for the LMWH group (OR 0.13, 95% CI 0.11-0.16, P < 0.001). CONCLUSION: Despite the absence of a specific antidote, LMWH was associated with substantially lower rates of post-DVT-prophylaxis cranial decompression. This indicates that UH may not be the safer alternative in TBI patients at high risk for intracranial hemorrhagic complications.